PMID- 31900015 OWN - NLM STAT- MEDLINE DCOM- 20200804 LR - 20200804 IS - 1744-5094 (Electronic) IS - 1381-6810 (Linking) VI - 40 IP - 6 DP - 2019 Dec TI - Macular maldevelopment in ATF6-mediated retinal dysfunction. PG - 564-569 LID - 10.1080/13816810.2019.1706749 [doi] AB - Background: Achromatopsia has been previously associated with mutations in the ATF6 gene. Rod-monochromatism, foveal hypoplasia, and disruption of the subfoveal photoreceptor layer are described as phenotypical features. We report detailed structural and electrophysiological assessment of two patients from two families, one manifesting severe macular maldevelopment and one with foveal hypoplasia.Materials and methods: The patients underwent a complete ophthalmic examination including electroretinography (ERG), spectral-domain optical coherence tomography (SD-OCT), fundus autofluorescence, and fundus photography. Genetic testing was performed by next-generation sequencing.Results: In one patient, fundoscopy and SD-OCT revealed well-demarcated coloboma-like excavated lesions at the central macula of both eyes. Genetic analysis identified a novel homozygous p.Asp140Ter mutation in the ATF6 gene. The second patient had foveal hypoplasia in association with a homozygous ATF6 mutation affecting a splice donor site (c.1187 + 5G>C). In both patients, electrophysiological assessment showed normal rod-specific (DA 0.01) and dark-adapted bright white-flash ERGs (DA 10.0). 30 Hz flicker ERGs were undetectable. There were low-amplitude single-flash photopic ERGs (LA 3.0) with timing and shape suggesting S-cone origin.Conclusions: The findings, particularly a case with severe macular maldevelopment, may expand on the phenotype previously associated with ATF6-mediated achromatopsia. In addition, the comprehensive electrophysiological assessment suggests that preserved S-cone activity can be detected in this particular molecular sub-type of cone dysfunction. FAU - Ritter, Markus AU - Ritter M AUID- ORCID: 0000-0003-1406-8340 AD - Moorfields Eye Hospital, London, UK. AD - Department of Ophthalmology, Medical University of Vienna, Vienna, Austria. FAU - Arno, Gavin AU - Arno G AD - UCL Institute of Ophthalmology, University College London, London, UK. FAU - Ba-Abbad, Rola AU - Ba-Abbad R AD - Moorfields Eye Hospital, London, UK. AD - UCL Institute of Ophthalmology, University College London, London, UK. FAU - Holder, Graham E AU - Holder GE AD - Moorfields Eye Hospital, London, UK. AD - UCL Institute of Ophthalmology, University College London, London, UK. AD - National University of Singapore, Department of Ophthalmology, National University Hospital, Singapore. FAU - Webster, Andrew R AU - Webster AR AUID- ORCID: 0000-0001-6915-9560 AD - Moorfields Eye Hospital, London, UK. AD - UCL Institute of Ophthalmology, University College London, London, UK. LA - eng PT - Case Reports PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200103 PL - England TA - Ophthalmic Genet JT - Ophthalmic genetics JID - 9436057 RN - 0 (ATF6 protein, human) RN - 0 (Activating Transcription Factor 6) RN - Foveal Hypoplasia, Isolated SB - IM MH - Activating Transcription Factor 6/*genetics MH - Adult MH - Color Vision Defects/*complications MH - Eye Diseases, Hereditary/etiology/genetics/*pathology MH - Female MH - Fovea Centralis/*abnormalities/pathology MH - *Homozygote MH - Humans MH - Macula Lutea/abnormalities/metabolism/*pathology MH - *Mutation MH - Nystagmus, Congenital/etiology/genetics/*pathology MH - Prognosis MH - Retina/*physiopathology OTO - NOTNLM OT - ATF6 OT - Achromatopsia OT - macular maldevelopment EDAT- 2020/01/05 06:00 MHDA- 2020/08/05 06:00 CRDT- 2020/01/05 06:00 PHST- 2020/01/05 06:00 [pubmed] PHST- 2020/08/05 06:00 [medline] PHST- 2020/01/05 06:00 [entrez] AID - 10.1080/13816810.2019.1706749 [doi] PST - ppublish SO - Ophthalmic Genet. 2019 Dec;40(6):564-569. doi: 10.1080/13816810.2019.1706749. Epub 2020 Jan 3.